APOE and Hypertension: The strengths of this study include: (1) a relatively large cohort; (2) inclusion of covariates such as age, gender, APOE ε4 carrier, hypertension, diabetes and cardiovascular diseases in analyses to reduce confounding; and (3) use of neuroimaging platforms to detect and quantify CeVD.